These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 33969928)
21. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210 [TBL] [Abstract][Full Text] [Related]
22. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
23. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas. Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471 [TBL] [Abstract][Full Text] [Related]
25. Pyroptosis: a novel signature to predict prognosis and immunotherapy response in gliomas. He G; Chen Z; Zhuo S; Tang J; Hao W; Yang K; Yang C Hum Cell; 2022 Nov; 35(6):1976-1992. PubMed ID: 36129672 [TBL] [Abstract][Full Text] [Related]
26. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma. Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186 [TBL] [Abstract][Full Text] [Related]
27. Multi Wu M; Li K; Liao Y; Li L; Xiao X; Chen Y; Guo J; Hu F; Qu J; Wang Z; Feng H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):159-174. PubMed ID: 38755712 [TBL] [Abstract][Full Text] [Related]
28. A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma. Jin J; Liu C; Yu S; Cai L; Sitrakiniaina A; Gu R; Li W; Wu F; Xue X Aging (Albany NY); 2021 Jun; 13(12):16144-16164. PubMed ID: 34115610 [TBL] [Abstract][Full Text] [Related]
29. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
30. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
31. A Novel Prognostic Signature Based on Glioma Essential Ferroptosis-Related Genes Predicts Clinical Outcomes and Indicates Treatment in Glioma. Yun D; Wang X; Wang W; Ren X; Li J; Wang X; Liang J; Liu J; Fan J; Ren X; Zhang H; Shang G; Sun J; Chen L; Li T; Zhang C; Yu S; Yang X Front Oncol; 2022; 12():897702. PubMed ID: 35756689 [TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma. Miao YD; Kou ZY; Wang JT; Mi DH World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046 [TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Wang F; Chen C; Chen WP; Li ZL; Cheng H Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125 [TBL] [Abstract][Full Text] [Related]
34. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma. Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170 [No Abstract] [Full Text] [Related]
35. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma. Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A Front Immunol; 2022; 13():961933. PubMed ID: 35990696 [TBL] [Abstract][Full Text] [Related]
36. Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma. Yue Z; Sun J; Shi L Front Genet; 2022; 13():887542. PubMed ID: 35692844 [TBL] [Abstract][Full Text] [Related]
37. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma. Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496 [TBL] [Abstract][Full Text] [Related]
38. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
39. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma. Luan Y; Chen Y; Wang Y; Shu M Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629061 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]